FOX40 interviews Frank Reynolds of InVivo Therapeutics (NVIV)

Jan. 19, 2012 7:26 PM ETNVIV
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Contributor Since 2012

We are an independent equity service dedicated to increasing the visibility of public and private companies worldwide. We specialize in healthcare, pharma/biotech, telecommunications, energy, and technology markets, and seek out companies demonstrating: Solid growth prospects Well-designed operating and growth strategies An experienced and proven management team Command of a niche position in a large and expanding market A unique or innovative position or technology Crystal Research Associates has been recognized on CNBC, CNBC Europe, Fox Business, Bloomberg, Bloomberg Radio, and CBS, among other networks, and in the International Herald Tribune, the South Florida Business Journal, MedAdNews, the New York Times, Forbes, BusinessWeek, PharmaLive, and CBS MarketWatch. CEO and Senior Analyst Jeffrey Kraws has also been consistently ranked on Wall Street among the Top Ten Analysts for pharmaceutical stock performance in the world for almost two decades as well as ranked several times as the number one stock performance analyst in the world for pharmaceuticals from Starmine and for estimates from Zacks. Additionally, he has been 5-Star Ranked for top biotechnology stock performance by Starmine.

Sacramento’s FOX40 interviews Frank Reynolds of InVivo Therapeutics (NVIV). Mr. Reynolds discusses his own experience with paralysis and how it led to his founding of InVivo Therapeutics. He also overviews the technology that InVivo is developing and its successes to date combating spinal injury/paralysis in monkeys. Highlights of the interview include mention that the Company’s first product does not require any drugs or stem cells. It is a unique medical device that Mr. Reynolds expects to hit the market by the end of 2013. For more details on InVivo Therapeutics and the work that this innovative company is performing, download a copy of Crystal Research Associates' comprehensive Executive Informational Overview on InVivo, published in December 2011.

To view the interview on FOX40′s webpage, click here.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.